Quick Summary
- SNOW shares plummeted 11.8% Thursday, closing around $132 after opening at $149.99
- Volume surged 152% above typical levels with more than 15 million shares traded
- Securities-fraud class-action lawsuit deadline set for April 27, 2026 heightens investor concerns
- Data breach involving third-party integrator sparked renewed security questions
- Widespread software sector decline fueled by concerns that AI agents threaten traditional SaaS business models
Thursday proved to be a painful session for Snowflake (SNOW) shareholders. Shares collapsed 11.8%, sliding from $149.99 down to approximately $132, while trading activity exploded to over 150% above normal daily levels. When volume spikes like that, it’s typically a signal that multiple catalysts are at work — and that’s exactly what happened here.
This wasn’t a single-headline story. Rather, it was a convergence of negative developments hitting simultaneously.
Legal troubles continue to cast a shadow over the company. Several law firms have issued investor notices related to a securities-fraud class-action suit covering transactions from June 2023 through February 2024. With the lead plaintiff deadline set for April 27, 2026, these announcements have resurfaced, keeping legal uncertainty front and center for shareholders.
Adding to investor anxiety are new disclosures about customer data compromises. While the security incidents stemmed from a breach at a third-party integration partner rather than Snowflake’s infrastructure directly, the company acknowledged detecting “unusual activity” — language that inevitably raises red flags for concerned investors.
Broader Software Selloff Hits Hard
Snowflake didn’t suffer in isolation Thursday. The entire software sector experienced significant downward pressure, with analysts attributing the decline to mounting concerns that AI-powered automation could erode demand for conventional enterprise software platforms. Cloudflare (NET) tumbled approximately 12%, ServiceNow (NOW) declined roughly 7%, and Snowflake got swept up in the same downdraft.
The underlying thesis is simple but powerful: if AI agents can automate tasks that currently require SaaS applications, those applications lose value. This repricing narrative has been percolating for months, and Thursday appeared to mark a significant selloff triggered by these fears.
Recent insider transactions haven’t helped market sentiment either. Company insiders have offloaded approximately $108 million in stock over the past quarter. Director Michael Speiser reduced his holdings by more than 62% in early March. EVP Christian Kleinerman disposed of 10,000 shares in February. These aren’t insignificant transactions.
The Optimistic View Persists
Even with Thursday’s decline, Wall Street analysts haven’t abandoned their positive outlook. The consensus rating still sits at “Moderate Buy” with a mean price target hovering around $249.62 — representing nearly 100% upside from current trading levels.
Bullish analysts point to Cortex AI, Snowflake’s integrated AI platform, and the expanding ecosystem of developers building applications on top of it. Healthcare technology firm Penguin AI exemplifies this trend, constructing workflow solutions directly within the Snowflake AI Data Cloud environment.
The company recently implemented Iceberg V3 compatibility, an enhancement that strengthens data portability and could address enterprise customer concerns about platform dependency.
Top-line growth continues to impress. Snowflake’s latest quarterly results showed revenue of $1.28 billion, representing 30.1% year-over-year expansion and exceeding analyst projections. Earnings per share reached $0.32, surpassing the $0.27 consensus estimate.
The challenge lies in profitability metrics. The company continues operating with a negative net margin of 28.43% and a negative return on equity of 50.61%. Year-to-date performance shows SNOW down more than 31%, trading significantly below both its 50-day moving average of $169.90 and its 200-day moving average of $213.12.
Rosenblatt Securities maintained a Buy rating with a $275 price target in late February. DA Davidson preserved its Buy stance while adjusting its target downward from $300 to $250. TD Cowen similarly maintained optimism but lowered expectations from $270 to $255.





